S&P 500 Hits Record High Above 6,400, 15th Milestone of...
Key Takeaways The S&P 500 has reached a new all-time high above 6,400, marking its 15th record close in 2025, fuelled by resilient corporate earnings and hopes of cooling inflation....
Key Takeaways The S&P 500 has reached a new all-time high above 6,400, marking its 15th record close in 2025, fuelled by resilient corporate earnings and hopes of cooling inflation....
Key Takeaways The Nasdaq 100 index has closed at a new all-time high, driven by sustained momentum in technology equities, particularly those involved in artificial intelligence and cloud computing. The...
Key Takeaways Investors are reportedly reallocating capital from high-performing volatile assets, such as cryptocurrency mining stocks, into BlackBerry, anticipating long-term growth driven by its QNX software. BlackBerry’s QNX division shows...
Key Takeaways The IPO market has shown a distinct revival in 2025, with global proceeds rising despite persistent market volatility, signalling a renewed window for public listings. This resurgence is...
Key Takeaways In the second quarter of 2025, elite investors made UnitedHealth Group (UNH) their top acquisition by volume, treating its significant share price decline as a deep value opportunity....
Key Takeaways HSBC has significantly raised its year-end 2025 target for the S&P 500 to 6,400 from a previous 5,600, signalling a pivot from its earlier caution. The upward revision...
Key Takeaways Early trading performance can hint at daily trends but is often reversed, making it an unreliable standalone indicator for market direction. Market breadth indicators, such as the advance-decline...
Key Takeaways Robust annual gains in the 30-40% range, while less sensational than triple-digit returns, are a powerful engine for long-term wealth creation through compounding. The pursuit of extraordinary “moonshot”...
Key Takeaways US corporate share buyback announcements reached a record $166 billion in July 2024, nearly doubling the previous high for the month set in 2006. The surge is primarily...
Key Takeaways A potential tariff escalation on imported pharmaceuticals, threatened to reach as high as 250%, could fundamentally alter the US drug market and its global supply chains. The proposed...
CTA Content